| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3087067 | Pratique Neurologique - FMC | 2016 | 7 Pages |
Abstract
Apomorphine administered by subcutaneous infusion has been used efficiently in parkinsonian patients to treat severe motor fluctuations and levodopa-induced dyskinesias. Despite increasing evidence of its efficacy and its relative safety, apomorphine infusion therapy is still underused. This article reviews pharmacokinetic properties, efficacy, tolerability and indications of apomorphine infusion in Parkinson's disease.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
S. Drapier, M. Auffret, M. Vérin, P. Sauleau,